Studying a new antibiotic combination for serious belly infections
Treatments studied
Part of Infections clinical trials.
This study tests a new combination of two antibiotics (meropenem and pralurbactam) given through an IV to treat serious abdominal infections. It is for adults who need hospital care and might be helped by a stronger infection-fighting drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a serious infection inside your belly (like an abscess or peritonitis) that needs treatment in the hospital.
- You have signs that the infection is affecting your whole body – for example, fever, belly pain, nausea, low blood pressure, a belly mass, or confusion.
- You do not have a known allergy to penicillin, cephalosporins, or carbapenem antibiotics.
- Your kidneys are working well (creatinine clearance > 50 mL/min).
- If you are able to become pregnant, you agree to use effective birth control and not breastfeed during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two antibiotics (meropenem and pralurbactam) for treating serious infections caused by bacteria that are resistant to many other antibiotics. It may be an option for hospitalized patients with pneumonia, urinary tract infections, abdominal infections, or bloodstream infections.
This trial tests two different schedules of a combination of antibiotics (ceftazidime-avibactam plus aztreonam) for people with serious infections caused by bacteria that are hard to treat. It aims to find the best way to give these medicines.
This trial tests a new antibiotic, HRS-8427, for people with complicated urinary tract infections (UTIs) or kidney infections. If you qualify, you would receive the study drug through an IV while in the hospital.
This trial is checking how well a combination of two antibiotics, aztreonam and avibactam, works in patients who have a specific type of drug-resistant bacterial infection in the belly or lungs. It aims to offer a new treatment option for infections that are hard to cure.
This trial studies whether cefiderocol plus ampicillin-sulbactam works better than colistin (sometimes with meropenem) for serious infections caused by carbapenem-resistant Acinetobacter baumannii (a hard-to-treat germ). It may help by finding a more effective antibiotic plan for people with these severe hospital-acquired infections.
This study tests a new antibiotic for children with difficult-to-treat urinary tract infections (UTIs). The medicine is given through an IV and may help when other antibiotics haven't worked.
Hear when a new Intra-Abdominal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.